Chest
-
Pulmonary Vascular Disease CasesSESSION TYPE: Case ReportsPRESENTED ON: Saturday, March 22, 2014 at 04:15 PM - 05:15 PMINTRODUCTION: Percutaneous vertebroplasty and kyphoplasty are both techniques used to treat vertebral fractures and consist in the application of polimethilmethacrilate (PMMA) into the vertebral body, working as cement. One of the complications is pulmonary embolism (PE) of PMMA due to leakage of cement into the perivertebral veins. We report one case of a patient with cement PE seen in our practice. ⋯ The following authors have nothing to disclose: Aarón Córdova, Inma AlfagemeNo Product/Research Disclosure Information.
-
COPD Epidemiology & Physiology PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: to evaluate quantitative CT analysis on the follow up of COPD patients who accepting valve lung volume reduction and try to explore its mechanism on the effect on COPD lung ⋯ The following authors have nothing to disclose: Huang Junfang, Wang Rui, Qiu Jianxin, Zhang Hong, Guangfa WangNo Product/Research Disclosure Information.
-
OSA PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: A cross-sectional review was performed in order to assess the ability of the neck circumference (NC) to predict the diagnosis of obstructive sleep apnoea syndrome (OSAS) in a population group from Timisoara, Romania. ⋯ The following authors have nothing to disclose: Stefan Mihaicuta, Izabella Anita Toth, Sorin ParalescuNo Product/Research Disclosure Information.
-
Tuberculosis PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: The efficacy of standard chemotherapy for Mycobacterium avium complex pulmonary disease (MAC-PD) is limited by poor clinical response rate, drug toxicity and side effects. When to start standard chemotherapy or which patients to treat remains undefined. In Japan, patients with MAC-PD are sometimes treated with erythromycin alone as an alternative therapy before or after standard chemotherapy to prevent disease progression. The rationale for this is that erythromycin has immunomodulatory properties independent of its antimicrobial effects. To date, however, monotherapy with erythromycin for MAC-PD is not well established. Therefore we investigated the safety, tolerability and possible clinical benefit of this treatment. ⋯ The following authors have nothing to disclose: Yukihiro Yano, Seigo Kitada, Masahide Mori, Soichiro Yokota, Ryoji MaekuraNo Product/Research Disclosure Information.
-
COPD Comorbidity PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: The effects of meteorological conditions on the frequency of COPD (chronic obstructive pulmonary disease) exacerbations. ⋯ The following authors have nothing to disclose: Burhan Akbas, Arzu MiriciNo Product/Research Disclosure Information.